Wang C X, Williams G M
Cancer Lett. 1987 Feb;34(2):173-85. doi: 10.1016/0304-3835(87)90008-5.
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and N-propyl-N'-nitro-N-nitrosoguanidine (PNNG) were administered to male F344 rats at a single dose of 200 mg/kg by gavage and the animals were observed for 110 weeks. The results revealed that PNNG was a weaker carcinogen for the stomach than MNNG under these conditions. After MNNG, the mortality of animals was higher and their average survival time was shorter than after PNNG. Neoplasms were induced in both the forestomach and glandular stomach by both agents. The incidence of forestomach tumors was high: 85% with MNNG, 64% with PNNG, but with PNNG a greater proportion of the forestomach neoplasms were benign. The incidence of neoplasms of the glandular stomach was 18% with PNNG as compared to 65% with MNNG. Intestinal metaplasia appeared in the glandular stomach after exposure to either MNNG or PNNG. There was also a high incidence in untreated control rats. Most glandular stomach neoplasms were composed of both gastric-type and intestinal-type epithelial elements. Only 3 cases of adenocarcinomas were composed solely of intestinal-type cells. These findings suggest that intestinal metaplasia may not necessarily be a preneoplastic stage.
通过灌胃以200mg/kg的单剂量给雄性F344大鼠施用N-甲基-N'-硝基-N-亚硝基胍(MNNG)和N-丙基-N'-硝基-N-亚硝基胍(PNNG),并对动物观察110周。结果显示,在这些条件下,PNNG对胃的致癌性比MNNG弱。给予MNNG后,动物的死亡率更高,平均存活时间比给予PNNG后更短。两种试剂均在前胃和腺胃中诱发肿瘤。前胃肿瘤的发生率很高:MNNG组为85%,PNNG组为64%,但PNNG组前胃肿瘤中良性肿瘤的比例更大。PNNG组腺胃肿瘤的发生率为18%,而MNNG组为65%。暴露于MNNG或PNNG后,腺胃中均出现肠化生。未处理的对照大鼠中肠化生的发生率也很高。大多数腺胃肿瘤由胃型和肠型上皮成分组成。仅3例腺癌仅由肠型细胞组成。这些发现表明,肠化生不一定是肿瘤前期阶段。